Labetalol blunts morning pressor surge in systolic hypertension

Hypertension

Volumn 11, Issue 2, 1988, Pages I-198-I-201

  DeQuattro, Vincent ^a   De Ping Lee, Debora ^a   Allen, John ^b   Sirgo, Mark ^c   Plachetka, John ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b White Memorial Medical Center   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Ambulatory blood pressure; Antihypertensive therapy; Left ventricular mass

Indexed keywords

LABETALOL;

ADULT; BLOOD PRESSURE; CLINICAL ARTICLE; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MALE; ORAL DRUG ADMINISTRATION;

BLOOD PRESSURE; CIRCADIAN RHYTHM; CLINICAL TRIALS; FEMALE; HEART RATE; HUMAN; HYPERTENSION; LABETALOL; MALE; MIDDLE AGE; PRESSORECEPTORS; TIME FACTORS;

EID: 0023945219     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.hyp.11.2_pt_2.i198     Document Type: Article

References (17)

1. Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension: the Framingham study. Circulation 1980;61:1179-1182
2. Kannel WB, Wolf PA, McGee DL, Dawber TR, McNamara P, Casielli WP. Systolic blood pressure, arterial rigidity and risk of stroke: the Framingham study. JAMA 1981;245:1225-1229
3. Curb JD, Borhani NO, Entwisle G, et al. Isolated systolic hypertension in 14 communities. Am J Epidemiol 1985;121:362-370
4. Garland C, Barrett-Connor E, Suarez L, Criqui MH. Isolated systolic hypertension and mortality after age 60 years: a prospective population-based study. Am J Epidemiol 1983;118:365-376
5. Millar-Craig MW, Bishop CN, Raftery EB. Orcadian variation of blood pressure. Lancet 1978;1:795-797
6. Agnoli A, Manfredi M, Mossutol, Piccinelli A. Rapport efttre les rythmes hemeronyctaux de la tension arterielle et sa pathogenic de 1'insuffisance vasculaire cerebrale. Rev Neurol 1975;131:597-606
7. Meyers A, Dewar HA. Circumstances attending 100 sudden deaths from coronary artery disease with coroners' necropsies. Br Heart J 1975;37:1133-1143
8. Bock KD, Kreuzenbeck W. Spontaneous blood pressure variations in hypertension; the effect of anti-hypertensive therapy and correlations with the incidence of complications. In: CIBA Symposium on Anti-hypertensive Therapy Principles and Practice. New York: CIBA, 1966:2234-237
9. Berglund G, De Faire U, Castenfors J, et al. Monitoring 24-hour blood pressure in a drug trial; evaluation of a noninvasive device. Hypertension 1985;7:688-694
10. Richards DA. Pharmacological effects of labetalol in man. Br J Clin Pharmacol 1976;3(suppl 3):721-723
11. Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocar-diographic findings. Circulation 1981;63:1391-1398
12. Mancia G, Pomidossi G, Parati G, et al. Blood pressure response to labetalol in twice and three times daily administration during a 24-hour period. Br J Clin Pharmacol 1982;13(suppl 1):27s-35s
13. Balasubramanian V, Mann M, Millar-Craig MW. Alterations in continuous ambulatory blood pressure after labetalol treatment in hypertensives. In: Fletcher E, ed. Glaxo symposium on labetalol, Florence, Italy, 1979:69-75
14. Fouad-Tarazi FM, Liebson PR. Echocardiographic studies of regression of left ventricular hypertrophy in hypertension. Hypertension 1987;9(suppl II):II-65-II-68
15. Drayer JIM, Weber MA, Gardin JM, Lipson JL. Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension. Am J Med 1983;75(suppl 3A): 113-120
16. Trimarco B, Wikstrand J. Regression of cardiovascular structural changes by antihypertensive treatment. Hypertension 1984;6(suppl III):III-150-III-157
17. Kaul U, Mohan JC, Bhatia ML. Effects of labetalol on left ventricular mass and function in hypertension-an assessment by serial echocardiography. Int J Cardiol 1984;5:461-469